Skip to content

XGenomes

YC W19 · Active · XGenomes is building the sequencing technology of the future.

Competitors

Adjacent

Also from W19

All of W19

About XGenomes

At XGenomes, we are building a technology comprising novel biochemistry, hardware and algorithms for sequencing DNA. Our product will be streamlined: there is zero library preparation; we sequence directly on unadulterated single molecules of DNA; DNA extraction will be integrated with sequencing; there is no bioinformatics bottleneck. The sequence we produce will be of unprecedented accuracy due to several layers of in-built redundancy including the sequencing both strands of the double-helix concurrently. The sequence we produce will be complete, encompassing: structural as well as single nucleotide variants; long-range haplotype phase; the repetitive "dark matter" of the genome. The cost of goods (consumables) of sequencing will be <$10, which will allow us to price our product at a level that will help grow the market while still achieving >90% margin. We will start by offering access as a service to high value customers, which be followed by a razor and blade model of selling instruments and consumables.

YC batch
W19 · Winter 2019
Status, per YC
Active
Category
Other
Team size
6
Location
Boston, MA, USA; Cambridge, MA, USA
Checked
33m ago

YC tags: Genomics

XGenomes in W19: 194 companies, 26% AI

XGenomes: questions

Which YC batch was XGenomes in?

XGenomes was in Y Combinator's Winter 2019 batch (W19).

Is XGenomes still active?

Y Combinator lists XGenomes as active.

Where is XGenomes based?

XGenomes lists Boston, MA, USA; Cambridge, MA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.